Behcet Syndrome is a rare, chronic, and multisystemic disorder characterized by recurrent oral and genital ulcers, skin lesions, and inflammation in various organs. The prevalence of Behcet Syndrome varies across different regions and ethnicities.
Although it is difficult to determine the exact prevalence due to underdiagnosis and misdiagnosis, it is estimated that Behcet Syndrome affects approximately 1 in 10,000 to 20,000 individuals worldwide. However, the prevalence can be significantly higher in certain populations, particularly in countries along the ancient Silk Road, such as Turkey, Iran, and Japan.
Behcet Syndrome predominantly affects individuals in their 20s and 30s, but it can occur at any age. Men are slightly more affected than women, especially in Middle Eastern and Asian populations. The exact cause of Behcet Syndrome remains unknown, but it is believed to involve a combination of genetic predisposition and environmental factors.
Early diagnosis and appropriate management are crucial in improving the quality of life for individuals with Behcet Syndrome. Treatment focuses on controlling symptoms, reducing inflammation, and preventing complications. A multidisciplinary approach involving rheumatologists, dermatologists, ophthalmologists, and other specialists is often necessary to provide comprehensive care.